FDA Gives Approval To Baxalta Drug Adynovate For Patients With Hemophilia A FDA gave approval to Baxalta drug Adynovate for the treatment of patients with Hemophilia A. The drug is said to stay longer in the blood, thus reducing the need for frequent injections. by Rina Marie Doctor
'Spray and Pray' iMessage Scam Haunts iPhone Owners: How to Avoid Losing Your Hard-Earned Money From it